Atelerix, a U.K.-based biotechnology company specializing in hydrogel encapsulation technology for cell preservation, has entered into a memorandum of understanding with Rodon Global, a South Africa-based freight company focused on clinical trials and drug discovery. The partnership aims to integrate Atelerix’s cryo-free preservation solutions into Rodon’s logistics services, addressing challenges in transporting temperature-sensitive biomaterials without freezing. The agreement allows Rodon ...